← All trials
NCT06781255
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 13, 2025
- Primary completion
- Dec 30, 2026
- Completion date
- Jul 31, 2027
- First posted
- Jan 17, 2025
- Last posted
- Mar 17, 2025
- Enrollment
- 5
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of KentuckyLead sponsor
- University of KentuckyOfficial
- University of KentuckySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.